TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer-Reference-Cited by-同舟云学术

TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer

Published:2022-01-28 Issue:11 Volume:41 Page:1589-1599
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Ma Yan,Zhang Haibo,Chen Cheng,Liu Lixin,Ding Ting,Wang Ying,Ma Dachang,Ling Xiaoling,Chen Xiaohua,Li Jianping,Guansheng ,Zhong ,Ru Guoqing,Zhang Lei,Tang Jianming^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02204-1.pdf

Reference38 articles.

1. Okawa T. [History of radiotherapy for cancer]. Gan Kagaku Ryoho. 1999;26:15–22.

2. He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Crit Rev Oncol Hematol. 2018;131:96–101.

3. He L, Lv Y, Song Y, Zhang B. The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity. Cancer Manag Res. 2019;11:5765–75.

4. Qiu L, Ma Y, Chen X, Zhou L, Zhang H, Zhong G, et al. Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway. J Transl Med. 2021;19:344.

5. Wang X, Zhang X, Qiu C, Yang N. STAT3 contributes to radioresistance in cancer. Front Oncol. 2020;10:1120.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression;Cell Death & Disease;2024-08-28

2. Subclinical dose irradiation triggers human breast cancer migration via mitochondrial reactive oxygen species;Cancer & Metabolism;2024-07-08

3. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

4. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling;Journal of Translational Medicine;2024-05-21

5. Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives;Expert Review of Anticancer Therapy;2024-03-21